Bayer HealthCare AG Sustainability Profile
Bayer HealthCare AG, a prominent subsidiary of Bayer AG, is headquartered in Leverkusen, Germany. Established in 1863, the company has evolved into a global leader in the pharmaceutical and life sciences industry, with significant operations across Europe, North America, and Asia. Bayer HealthCare focuses on key business areas such as prescription pharmaceuticals, consumer health products, and animal health, offering innovative solutions that address critical health challenges. Its core products, including advanced therapies in oncology, cardiology, and women's health, are distinguished by their commitment to research and development. With a strong market position, Bayer HealthCare has achieved numerous accolades for its contributions to healthcare, consistently prioritising patient needs and scientific excellence. The company's dedication to innovation and quality continues to set it apart in a competitive landscape.
DitchCarbon Score
How does Bayer HealthCare AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bayer HealthCare AG's score of 90 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bayer HealthCare AG, headquartered in Germany (DE), currently does not have specific carbon emissions data available for the most recent year. However, the company is part of a corporate family that includes Bayer Aktiengesellschaft, from which it inherits emissions data and climate commitments. Bayer Aktiengesellschaft has set ambitious climate targets, including commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). These initiatives aim to significantly reduce greenhouse gas emissions across various scopes, including Scope 1, 2, and 3 emissions. The specific reduction targets and achievements for Bayer HealthCare AG are not detailed, but they align with the overarching goals of Bayer Aktiengesellschaft. As a merged entity, Bayer HealthCare AG benefits from the climate strategies and performance metrics established by Bayer Aktiengesellschaft, which are designed to enhance sustainability and reduce carbon footprints across its operations. The company is committed to addressing climate change and improving its environmental impact, although specific numerical targets or achievements have not been disclosed at this time.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 3 | 1,215 | 0,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Bayer HealthCare AG's Industry?
How Carbon Intensive is Bayer HealthCare AG's Location?
Bayer HealthCare AG's Scope 3 Categories Breakdown
Bayer HealthCare AG's Scope 3 emissions, which decreased by 16% last year and increased significantly since 2004, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 72% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 76% of Scope 3 emissions.
Top Scope 3 Categories
Bayer HealthCare AG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bayer HealthCare AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
